China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Change in Inventory came in at -$247492.0 in Q1 2026, down 58.01% YoY from -$589457.9 in Q1 2025, and down 17.54% on a QoQ basis from -$210551.0 in Q4 2025.
China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Change in Inventory data on file, last reported at -$247492.0 in Q1 2026.
- Quarterly Change in Inventory fell 58.01% year-over-year to -$247492.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$680626.0 (up 58.13% YoY) and the FY2025 annual result came in at -$589761.0, up 63.3% from the prior year.
- Change in Inventory declined to -$247492.0 in Q1 2026, from -$210551.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $552686.0 in Q1 2023 to a low of -$582187.0 in Q3 2022.
- A 5-year average of -$183305.1 and a median of -$210551.0 in 2025 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 311.81% in 2022, down 533.35% in 2022.
- Tracing CPHI's Change in Inventory over 5 years: stood at -$192902.0 in 2022, then plunged by 34.09% to -$258659.0 in 2023, then tumbled by 97.56% to -$510996.0 in 2024, then surged by 58.8% to -$210551.0 in 2025, then slipped by 17.54% to -$247492.0 in 2026.
- The last three Change in Inventory figures came in at -$247492.0 (Q1 2026), -$210551.0 (Q4 2025), and -$57779.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 41.33 Mn | 41.02 Mn | 83,566.00 | -272,929.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247,492.00 |
| Mar 31, 2026 | -247,492.00 |
| Dec 31, 2025 | -210,551.00 |
| Dec 31, 2025 | -210,551.00 |
| Sep 30, 2025 | -57,779.00 |
| Sep 30, 2025 | -57,779.00 |
| Jun 30, 2025 | -164,804.00 |
| Jun 30, 2025 | -164,804.00 |
| Mar 31, 2025 | -156,627.00 |
| Mar 31, 2025 | -156,627.00 |
| Dec 31, 2024 | -510,996.00 |
| Dec 31, 2024 | -510,996.00 |
| Sep 30, 2024 | -376,771.00 |
| Sep 30, 2024 | -376,771.00 |
| Jun 30, 2024 | -581,031.00 |
| Jun 30, 2024 | -581,031.00 |
| Mar 31, 2024 | -138,090.00 |
| Mar 31, 2024 | -138,090.00 |
| Dec 31, 2023 | -258,659.00 |
| Dec 31, 2023 | -258,659.00 |